Multus Biotechnology Limited
About
Multus designs cell culture media with lab robotics and machine learning. Our MediOp platform screens thousands of formulations per campaign and optimises growth, titre and product quality together, using more than 50 million culture data points across CHO, HEK293, mesenchymal stem cells and other cell lines. We run paid media design programmes for global media suppliers, CDMOs and biologics developers, and have led several Innovate UK engineering biology projects.
Imperial College London spin-out, founded 2020. About 20 staff. Labs and offices at White City, London.
What we are looking for in this call
A Singapore company to co-develop a manufacturing process with us, where the medium and the process are designed together. Good fits:
-
Biologics developers, biosimilar makers and CDMOs running CHO processes (antibodies, recombinant proteins)
-
Cell therapy, exosome or viral vector CDMOs
-
Developers scaling MSC, T cell or NK cell therapies
-
Bioreactor and bioprocess equipment makers
-
Media ingredient and reagent suppliers
What we bring
-
AI-led media design and closed-loop optimisation, including CHO fed-batch titre and quality
-
High-throughput automated culture and analytics
-
Experience leading Innovate UK collaborative R&D
-
A route to market through media supplier licensing
Contact Cai Linton, CEO, to discuss a joint project.
Representatives
Co-founder and CEO of Multus
Multus Biotechnology Limited